Direct comparison of the diagnostic performance of growth differentiation factor 8 in pediatric versus adult heart failure
-
Published:2024-04
Issue:
Volume:557
Page:117883
-
ISSN:0009-8981
-
Container-title:Clinica Chimica Acta
-
language:en
-
Short-container-title:Clinica Chimica Acta
Author:
Burger Achim Leo,
Hauser Jakob A,
Kaider Alexandra,
Stojkovic Stefan,
Diedrich André,
Michel-Behnke Ina,
Huber Kurt,
Wojta Johann,
Pezawas Thomas,
Demyanets SvitlanaORCID
Reference38 articles.
1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur. Heart J.,2021
2. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update;Cantinotti;Heart Fail. Rev.,2014
3. The clinical utility of brain natriuretic peptide in paediatric left ventricular failure;Mangat;Eur. J. Heart Fail.,2009
4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure;von Haehling;J. Am. Coll. Cardiol.,2007
5. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction;Santhanakrishnan;Eur. J. Heart Fail.,2012